Back to School: How biopharma can reboot drug development. Access exclusive analysis here

p38 kinase inhibitor: Began Phase I testing

Scios Inc. (SCIO), Sunnyvale, Calif.
Product:

Read the full 63 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE